Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia
Clinical trial NCT02079844 · COMPLETED
Trial details
- NCT number
- NCT02079844
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2015-06-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.